Ashley Hall insider trades

Open-market stock purchases and sales by Ashley Hall, Chief Development Officer at Structure Therapeutics Inc, from SEC Form 4 filings since Jan 28, 2021.

Recent trades

DateStockTradeValue
Mar 19, 2026GPCR Structure Therapeutics IncBought (not open market)—
Mar 19, 2026GPCR Structure Therapeutics IncBought (not open market)—
Mar 3, 2026GPCR Structure Therapeutics IncSold (not open market)$102K
Nov 20, 2025GPCR Structure Therapeutics IncBought (not open market)—

Companies traded

  • GPCR Structure Therapeutics Inc: other filings, last Mar 19, 2026
  • RPHM Reneo Pharmaceuticals, Inc: 1 sale, last Aug 28, 2023
  • ESPR Esperion Therapeutics, Inc: other filings, last Jan 28, 2021

Get free alerts when Ashley Hall files a new trade →